Processa Pharmaceuticals, Inc. Issuance of Stock and Warrants for Services or Claims
Processa Pharmaceuticals, Inc. (PCSA) reported Issuance of Stock and Warrants for Services or Claims of $1.31 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims · last filed 2025-03-20
- Processa Pharmaceuticals, Inc. issuance of stock and warrants for services or claims for the quarter ending 2023-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. issuance of stock and warrants for services or claims for the quarter ending 2023-09-30 was $0.00.
- Processa Pharmaceuticals, Inc. issuance of stock and warrants for services or claims for the quarter ending 2023-06-30 was $0.00.
- Processa Pharmaceuticals, Inc. issuance of stock and warrants for services or claims for the quarter ending 2023-03-31 was $1.31M.
- Processa Pharmaceuticals, Inc. issuance of stock and warrants for services or claims for fiscal 2023 was $1.31M.
| Period end | Issuance of Stock and Warrants for Services or Claims 3 month | Issuance of Stock and Warrants for Services or Claims 6 month | Issuance of Stock and Warrants for Services or Claims 9 month | Issuance of Stock and Warrants for Services or Claims 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $1.31M 10-K · filed 2025-03-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $1.31M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.31M 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $1.31M 10-Q · filed 2024-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |